Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs1015849 | chr19:37946180 | G/A | 1.76E-13 | 133 | 45.47 | 36.12 | 17.1 | KM Plot |
| TGCT | rs10161520 | chr12:107101685 | T/C | 0.000113 | 133 | 42.27 | 45.1 | 28.8 | KM Plot |
| TGCT | rs10165641 | chr2:54754494 | A/G | 8.23E-5 | 133 | 45.7 | 44.05 | 20.6 | KM Plot |
| TGCT | rs10173686 | chr2:221240757 | A/G | 1.95E-6 | 134 | 72.23 | 16.53 | 45.47 | KM Plot |
| TGCT | rs10189545 | chr2:121953148 | G/A | 1.0E-8 | 134 | 41.27 | 60.63 | 20.6 | KM Plot |
| TGCT | rs10194929 | chr2:242137372 | C/G | 0.000159 | 133 | 120.27 | 41.8 | 41.97 | KM Plot |
| TGCT | rs10219038 | chr10:1121814 | G/A | 2.26E-13 | 132 | 42.03 | 66.9 | 17.1 | KM Plot |
| TGCT | rs10240211 | chr7:23687039 | C/G | 6.8E-5 | 129 | 30.45 | 37.1 | 48.35 | KM Plot |
| TGCT | rs10253843 | chr7:23684965 | C/T | 6.83E-5 | 129 | 30.45 | 36.23 | 49.93 | KM Plot |
| TGCT | rs10258271 | chr7:127766400 | C/G | 1.58E-5 | 134 | 46.7 | 33.53 | 45.83 | KM Plot |
| TGCT | rs10269243 | chr7:23686785 | A/G | 6.83E-5 | 129 | 30.45 | 36.23 | 49.93 | KM Plot |
| TGCT | rs10403582 | chr19:37947839 | C/T | 1.37E-13 | 134 | 45.47 | 37.53 | 17.1 | KM Plot |
| TGCT | rs10407084 | chr19:37907792 | T/C | 1.76E-13 | 133 | 45.47 | 36.12 | 17.1 | KM Plot |
| TGCT | rs10409204 | chr19:37917692 | G/A | 2.27E-13 | 132 | 45.1 | 36.12 | 17.1 | KM Plot |
| TGCT | rs10411574 | chr19:38001879 | G/T | 1.78E-13 | 133 | 46.3 | 35.03 | 17.1 | KM Plot |